Clinical and laboratory findings of 21 patients with radiation-induced myopathy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 2, 2015, Pages 152-158

  Ghosh, Partha S ^a   Milone, Margherita ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATINE KINASE; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONNECTIVE TISSUE; CREATINE KINASE BLOOD LEVEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPERCAPNIA; LABORATORY TEST; LATENT PERIOD; MALE; MEDICAL RECORD REVIEW; MORTALITY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NASOPHARYNX CANCER; NECK PAIN; NONHODGKIN LYMPHOMA; PINEAL BODY TUMOR; RADIATION EXPOSURE; RADIATION FIELD; RADIATION INDUCED MYOPATHY; RADIATION INJURY; RESPIRATORY FAILURE; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; ATROPHY; BLOOD; COMPLICATION; LUNG FUNCTION TEST; MIDDLE AGED; MUSCULAR DISEASES; NECROSIS; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; RADIATION INJURIES; RETROSPECTIVE STUDY; SKELETAL MUSCLE; TIME; UNITED STATES;

ADULT; AGED; ATROPHY; CREATINE KINASE; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MUSCLE, SKELETAL; MUSCULAR DISEASES; NECROSIS; NEOPLASMS; RADIATION INJURIES; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84921370183     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307447     Document Type: Article

References (28)

1. Saarto T, Janes R, Tenhunen M, et al . Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 2002;6:323-30.
2. Chow E, Wu J, Loblaw A, et al. Radiotherapeutic approaches to metastatic disease. World J Urol 2003;21:229-42.
3. O'Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 2003;66:323-6.
4. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989;16:83-101.
5. Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R 2011;3:1041-154.
6. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007;109:1878-86.
7. De Bruin ML, Dorresteijn LD, van't Veer MB, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009;101:928-37.
8. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin 's lymphoma. J Clin Oncol 2007;25:1489-97.
9. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer 100 cases. Neurology 1981;31:45-50.
10. Johansson AS, Erlanson M, Lenner P, et al. Late side-effects are common after treatment of Hodgkin' s disease. Muscular atrophy following radiotherapy is a neglected risk. Lakartidningen 1998;95:44-7. (Swedish).
11. Aggarwal S, Amato A. Radiation induced myopathy following mantle field radiation for Hodgkin's disease: A report of 4 cases. Neurology 2007;68(Suppl 1):P05.107 (Abstract).
12. Furby A, Behin A, Lefaucheur JP, et al. Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series. J Neurol Neurosurg Psychiatry 2010;81:101-4.
13. Portlock CS, Boland P, Hays AP, et al. Nemaline myopathy: a possible late complication of Hodgkin 's disease therapy. Hum Pathol 2003;34:816-18.
14. Rowin J, Cheng G, Lewis SL, et al. Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease. Muscle Nerve 2006;34:666-9.
15. van Leeuwen-Segarceanu EM, Dorresteijn LD, Pillen S, et al. Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys 2012;82:612-18.
16. Klimm B, Eich HT, Haverkamp H, et al. Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: An analysis from the German Hodgkin Study Group. Ann Oncol 2007;18:357-63.
17. Aleman BM, Raemaekers JM, Tomisic R, et al. Involved-fi eld radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2007;67:19-30.
18. Hashimoto Y, Maebayashi K, Izumi S, et al. Dropped head syndrome induced by chemoradiotherapy for nasopharyngeal carcinoma: a case report. Jpn J Clin Oncol 2012;42:1091-3.
19. Umapathi T, Chaudhry V, Cornblath D, et al. Head drop and camptocormia. J Neurol Neurosurg Psychiatry 2002;73:1-7.
20. Barkhaus PE, Periquet I, Nandekar SD. Quantitative Motor unit action potential analysis in paraspinal muscles. Muscle Nerve 1997;20:373-5.
21. De Carvalho M, Pinto S, Swash M. Motor unit changes in thoracic paraspinal muscles in amyotrophic lateral sclerosis. Muscle Nerve 2009;39:83-6.
22. Welsh JS, Torre TG, DeWeese TL, et al. Radiation myositis. Ann Oncol 1999;10:1105-8.
23. Datta K, Suman S, Kallakury BV, et al. Exposure to heavy ion radiation induces persistent oxidative stress in mouse intestine. PLoS One 2012;7:e42224.
24. Barjaktarovic Z, Schmaltz D, Shyla A, et al. Radiation induced signaling results in mitochondrial impairment in mouse heart at 4 weeks after exposure to X-rays. PLoS One 2011;6:e27811.
25. Alameddine HS, Dehaupas M, Fardeau M. Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro. An experimental model for testing cultured cell myogenicity. Muscle Nerve 1989;12:544-55.
26. Fajardo LF, Berthrong M. Vascular lesions following radiation. Pathol Annu 1988;23:297-330.
27. Milliat F, Francois A, Isoir M, et al. Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages. Am J Pathol 2006;169:1484-95.
28. Wegrowski J, Lafuma C, Lefaix JL, et al. Modification of collagen and noncollagenous proteins in radiation-induced muscular fibrosis. Exp Mol Pathol 1988;48:273-85.